Taipei Exchange - Delayed Quote TWD
Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)
98.30
+0.60
+(0.61%)
At close: May 2 at 1:30:17 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Chonghan Wu Ph.D. | Founder & Chairman | -- | -- | -- |
| Mao Yuan Lin | GM & Director | -- | -- | -- |
| Rocky Shih | Co-Founder | -- | -- | -- |
| Nan Hu Wei | CFO & Head of Administration Division | -- | -- | -- |
Gongwin Biopharm Holdings Co., Ltd.
No. 80, Jianguo North Road
3rd Floor Section 1 Zhongshan District
Taipei, 104
Taiwan
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Gongwin Biopharm Holdings Co., Ltd., a clinical-stage biopharmaceutical company, develops anticancer drugs. It is developing PTS302, which has completed Phase III clinical trials for the treatment of lung cancer; PTS100, which is in Phase II clinical trials for the treatment of liver cancer; PTS-02 for the treatment of adenoid cystic carcinoma; and PTS500 for the treatment of malignant pleural effusion. The company was founded in 2014 and is based in Taipei, Taiwan.
Corporate Governance
Gongwin Biopharm Holdings Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
4194.TWO Holy Stone Healthcare Co., Ltd.
7.86
-0.76%
6838.TW Formosa Pharmaceuticals, Inc.
25.75
-0.19%
6550.TW Polaris Group
36.90
+0.27%
4147.TWO TaiMed Biologics Inc.
81.70
-0.12%
4168.TWO GlycoNex Incorporation
18.50
+0.54%
6657.TW Energenesis Biomedical CO.,LTD.
60.60
-0.16%
4171.TWO GeneReach Biotechnology Corp.
20.50
-1.44%
4162.TWO PharmaEngine, Inc.
89.70
+0.56%
6535.TWO Lumosa Therapeutics Co., Ltd.
166.50
+1.83%
6586.TWO CHO Pharma, Inc.
43.05
-2.05%